KR102052530B1 - Manufacturing Method of Fermented Red Ginseng Using Steamed Ginseng and Microorganism - Google Patents
Manufacturing Method of Fermented Red Ginseng Using Steamed Ginseng and Microorganism Download PDFInfo
- Publication number
- KR102052530B1 KR102052530B1 KR1020190067948A KR20190067948A KR102052530B1 KR 102052530 B1 KR102052530 B1 KR 102052530B1 KR 1020190067948 A KR1020190067948 A KR 1020190067948A KR 20190067948 A KR20190067948 A KR 20190067948A KR 102052530 B1 KR102052530 B1 KR 102052530B1
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng
- red ginseng
- present
- aspergillus
- fermented red
- Prior art date
Links
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 69
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 67
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 66
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 64
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 17
- 241000208340 Araliaceae Species 0.000 title claims abstract description 5
- 244000005700 microbiome Species 0.000 title abstract description 7
- RWXIFXNRCLMQCD-JBVRGBGGSA-N (20S)-ginsenoside Rg3 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RWXIFXNRCLMQCD-JBVRGBGGSA-N 0.000 claims abstract description 31
- 238000010025 steaming Methods 0.000 claims abstract description 30
- 238000001035 drying Methods 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 18
- XIRZPICFRDZXPF-UHFFFAOYSA-N Ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CC(O)C3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O XIRZPICFRDZXPF-UHFFFAOYSA-N 0.000 claims abstract description 13
- 241000228212 Aspergillus Species 0.000 claims description 15
- 240000006439 Aspergillus oryzae Species 0.000 claims description 13
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 11
- 238000000855 fermentation Methods 0.000 claims description 9
- 230000004151 fermentation Effects 0.000 claims description 9
- 244000063299 Bacillus subtilis Species 0.000 claims description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 5
- 241001513093 Aspergillus awamori Species 0.000 claims description 3
- 241000122821 Aspergillus kawachii Species 0.000 claims description 3
- 241000228245 Aspergillus niger Species 0.000 claims description 3
- 241000228136 Aspergillus shirousami Species 0.000 claims description 3
- 241001112078 Aspergillus usamii Species 0.000 claims description 2
- 241000193749 Bacillus coagulans Species 0.000 claims description 2
- 229940054340 bacillus coagulans Drugs 0.000 claims description 2
- 235000013305 food Nutrition 0.000 abstract description 13
- 239000000203 mixture Substances 0.000 abstract description 8
- 230000036541 health Effects 0.000 abstract description 7
- 230000000144 pharmacologic effect Effects 0.000 abstract description 7
- 238000011161 development Methods 0.000 abstract description 4
- 230000018109 developmental process Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 230000001766 physiological effect Effects 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 abstract description 2
- 238000012864 cross contamination Methods 0.000 abstract description 2
- 235000013376 functional food Nutrition 0.000 abstract description 2
- 241000228257 Aspergillus sp. Species 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 description 63
- 241000193830 Bacillus <bacterium> Species 0.000 description 13
- 229930182494 ginsenoside Natural products 0.000 description 11
- 229930182490 saponin Natural products 0.000 description 10
- 150000007949 saponins Chemical class 0.000 description 10
- 235000017709 saponins Nutrition 0.000 description 10
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 8
- 235000013361 beverage Nutrition 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229940089161 ginsenoside Drugs 0.000 description 5
- 238000011081 inoculation Methods 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000012669 liquid formulation Substances 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 2
- 240000005373 Panax quinquefolius Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 2
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 241000168720 Panax japonicus Species 0.000 description 1
- 235000003174 Panax japonicus Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 241001527087 Panax vietnamensis Species 0.000 description 1
- 235000017726 Panax vietnamensis Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000006993 memory improvement Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 208000020470 nervous system symptom Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/10—General methods of cooking foods, e.g. by roasting or frying
- A23L5/13—General methods of cooking foods, e.g. by roasting or frying using water or steam
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/38—Multiple-step
Abstract
Description
본 발명은 진세노사이드(ginsenoside) Rg3 함량이 증가된 발효홍삼의 제조방법에 관한 것으로, 더욱 자세하게는 1회 증숙한 인삼에 아스퍼질러스(Aspergillus) 속 균주 및/또는 바실러스(Bacillus) 속 균주를 접종하여 발효시킨 후 반복적인 증숙 및 건조 과정을 거쳐 진세노사이드 Rg3 함량을 증진시킨 발효홍삼의 제조방법 및 상기 방법에 의해 제조된 발효홍삼을 포함하는 식품 조성물에 관한 것이다.The present invention relates to a method for preparing fermented red ginseng with increased ginsenoside Rg3 content, and more particularly, to the Aspergillus strain and / or Bacillus sp. The present invention relates to a method for preparing fermented red ginseng which has been enhanced by ginsenoside Rg3 content through repeated steaming and drying, and a food composition comprising fermented red ginseng prepared by the method.
인삼은 반음지성 식물로서 오가피과(Araliaceae), 인삼속(Panax)에 속 식물로, 성질은 약간 따뜻하고 맛은 달고 약간 쓰며, 건강 증진과 질병 예방의 효과가 있는 대표적 한약재로 사용되어 왔다. 인삼은 수삼(水蔘, freshginseng)을 그대로 사용하거나, 건조시켜 백삼(白蔘, white ginseng)의 형태로 제조하여 사용하거나 또는 증숙 시켜서 홍삼(紅蔘, red ginseng)의 형태로 제조하여 사용되었다.Ginseng is a semi-negative plant, a genus of the genus Araliaceae and Panax. Its properties are slightly warm, sweet and slightly used, and it has been used as a representative herbal medicine for promoting health and preventing diseases. Ginseng (fresh ginseng) was used as it is, or dried and prepared in the form of white ginseng (白 蔘, white ginseng) or steamed red ginseng (紅 蔘, red ginseng) was used in the form of.
최근에는, 가공된 인삼에만 존재하는 인삼사포닌의 함량을 더욱 높이기 위한 많은 연구가 진행되었으며, 그 결과 태극삼(太極參, taeguk ginseng), 흑삼(黑參, black ginseng) 등의 가공인삼이 개발되었다. 특히, 흑삼은 수회 증숙 및 건조 과정을 거쳐 인삼이 검은색으로 변한 삼을 의미하는 것으로서, 수회 증숙 및 건조 과정을 거치면서 기본적으로 존재하는 인삼사포닌이 소실되지 않을 뿐만 아니라, 가공된 인삼에만 존재하는 인삼사포닌의 함량이 증진되는 것으로 알려져 있어, 이러한 흑삼을 보다 효과적으로 제조하는 방법에 대한 연구가 활발하게 수행되고 있다.Recently, many studies have been conducted to further increase the content of ginseng saponin present only in processed ginseng. As a result, processed ginseng such as taeguk ginseng and black ginseng have been developed. In particular, black ginseng means ginseng that has been changed to black through several steaming and drying processes, and the ginseng saponin which is basically present during several steaming and drying processes is not lost, and is present only in processed ginseng. Since the content of ginseng saponin is known to be enhanced, research on a method of more effectively producing such black ginseng has been actively conducted.
과거 인삼의 약리효능을 강화시킨 예로서 인삼의 가공방법에 따라 백삼제품과 홍삼제품으로 구별될 수 있으며, 특정 성분의 진세노사이드 함량이 백삼에 비하여 홍삼이 훨씬 더 높아, 이러한 함량 차이로 인하여 홍삼제품의 약리효능이 더 뛰어나다. 또한 인삼의 약리효능을 강화시키기 위한 수삼(인삼)의 가공방법으로 열처리에 의한 방법, 산 및 효소에 의한 방법, 미생물에 의한 방법 등이 알려져 있으며, 열처리에 의한 방법은 구증구포(九蒸九曝)에 의한 흑삼의 제조방법과 홍삼 농축액 및 추출액을 고온, 고압 처리하는 방법이 잘 알려져 있다.As an example of strengthening the pharmacological efficacy of ginseng in the past, it can be divided into white and red ginseng products according to the processing method of ginseng, and the ginsenoside content of certain ingredients is much higher than that of white ginseng. The pharmacological effect of the product is better. In addition, as a processing method of ginseng (ginseng) to enhance the pharmacological effect of ginseng, a method by heat treatment, a method by acid and enzyme, a method by microorganisms, etc. are known. The method of preparing black ginseng and the method of treating red ginseng concentrate and extract at high temperature and high pressure are well known.
최근 들어 홍삼에 함유된 유용한 성분들 중에서 암 예방 및 항암작용 효능이 보다 뛰어난 진세노사이드 Rg3, Rb1과 같은 특정성분의 변환에 대한 선택성을 높여 암 예방 및 항암작용의 약리활성이 뛰어난 고부가가치의 건강식품 등을 제조하는 기술이 요구되고 있다. 홍삼은 증숙 후 건조하는 과정에서 유효 성분이 보다 농축되는데, 사포닌과 같은 인체에 유효한 생리활성 성분이 생성되어 소화흡수가 잘 되고 면역체계 증진 및 기능강화에 도움을 줄 수 있다.Recently, high value-added health with excellent pharmacological activity of cancer prevention and anticancer activity by increasing the selectivity for conversion of specific ingredients such as ginsenoside Rg3 and Rb1, which is more effective in cancer prevention and anticancer activity among red ginseng. There is a demand for technology for manufacturing foods and the like. In red ginseng, the active ingredient is more concentrated during the steaming and drying process. The red ginseng produces a physiologically active ingredient, such as saponin, which is effective for digestion and absorption, and may help to enhance the immune system and strengthen the function.
사포닌은 화학적으로 배당체(glycoside)라 부르는 화합물의 일종이다. 식물의 뿌리, 줄기, 잎, 껍질, 씨 등에 포함되어 있으며, 항암, 항산화, 콜레스테롤 저하에 효과적인 생리활성물질로서 진세노사이드(ginsenoside)라 불린다. 진세노사이드의 종류는 약 30여종으로, 그 중 진세노사이드 Rb1이 전체 사포닌의 약 23%를 차지할 정도로 가장 함유량이 많고, Rg1이 약 19%, Re가 15%, Rb2가 11%, Rc가 12%, Rd가 약 7% 함유되어 있다고 알려져 있다. 여러 종류의 진세노사이드 중 Rg3는 백삼에는 없고 산삼과 홍삼에만 미량으로 존재하는 성분이다.Saponins are a chemical compound called glycosides. It is contained in the roots, stems, leaves, bark, and seeds of plants, and is called ginsenoside as a bioactive substance effective for anticancer, antioxidant, and cholesterol lowering. There are about 30 kinds of ginsenosides, of which ginsenoside Rb1 is the most abundant, accounting for about 23% of all saponins, about 19% Rg1, 15% Re, 11% Rb2, and Rc It is known to contain 12% and about 7% of Rd. Of the various ginsenosides, Rg3 is present in trace amounts of wild ginseng and red ginseng.
진세노사이드 Rg3는 혈전생성을 억제하고 혈소판의 응집을 억제하며, 혈관을 확장하여 혈액순환을 촉진 하며 혈압을 떨어뜨리는 효능이 있다. 또한 암세포의 전이를 억제하고 항암제에 대한 내성의 발생을 억제하며 치매예방작용이 강한 효능이 있다. Rg3는 효과가 뛰어나지만 홍삼에만 미량으로 존재하기 때문에 홍삼 내의 Rg3의 함유량을 높이기 위한 연구가 진행되어 왔다.Ginsenoside Rg3 inhibits thrombus formation, inhibits platelet aggregation, expands blood vessels, promotes blood circulation, and decreases blood pressure. In addition, it inhibits the metastasis of cancer cells, inhibits the development of resistance to anticancer drugs, and has a strong effect of preventing dementia. Although Rg3 is excellent in effect, only a small amount of red ginseng has been studied to increase the content of Rg3 in red ginseng.
이에 본 발명자들은 홍삼에 미량 포함되어 있는 진세노사이드 Rg3의 함량을 증가시키고, 그에 따라 항산화 기능이 강화된 홍삼을 제조하기 위하여, 1회 증숙한 인삼에 유용 미생물을 접종하여 발효시키고 추가로 증숙 및 건조 단계를 8회 반복하여 발효홍삼을 제조하였으며, 제조된 발효홍삼의 Rg3 함량이 증가됨을 확인하고, 본 발명을 완성하였다.In order to increase the content of ginsenoside Rg3 contained in trace amounts of red ginseng, and to prepare red ginseng with enhanced antioxidant function, the present inventors inoculated and fermented with useful microorganisms once steamed ginseng and further steaming and Fermented red ginseng was prepared by repeating the drying step eight times, and it was confirmed that the Rg3 content of the prepared fermented red ginseng was increased, thereby completing the present invention.
본 배경기술 부분에 기재된 상기 정보는 오직 본 발명의 배경에 대한 이해를 향상시키기 위한 것이며, 이에 본 발명이 속하는 기술분야에서 통상의 지식을 가지는 자에게 있어 이미 알려진 선행기술을 형성하는 정보를 포함하지 않을 수 있다.The above information described in this Background section is only for improving the understanding of the background of the present invention, and therefore does not include information that forms a prior art known to those of ordinary skill in the art. You may not.
본 발명의 목적은 생리활성을 나타내는 인삼사포닌 성분인 Rg3의 함량이 증가된 발효홍삼의 제조방법을 제공하는 데 있다.An object of the present invention is to provide a method for producing fermented red ginseng with increased content of Rg3, a ginseng saponin component exhibiting physiological activity.
본 발명의 다른 목적은 Rg3의 함량이 증가된 발효홍삼을 제공하는 데 있다.Another object of the present invention to provide a fermented red ginseng with an increased content of Rg3.
본 발명의 또 다른 목적은 Rg3의 함량이 증가된 발효홍삼을 포함하여 건강에 도움이 되는 식품을 제공하는 데 있다.Still another object of the present invention is to provide a food that is beneficial to health, including fermented red ginseng with an increased content of Rg3.
상기 목적을 달성하기 위하여, 본 발명은 (a) 1회 증숙한 인삼에 아스퍼질러스(Aspergillus) 속 균주 및/또는 바실러스(Bacillus) 속 균주를 접종하여 발효시키는 단계; (b) 상기 발효된 인삼을 증숙하고 건조하는 단계; 및 (c) 상기 (b) 단계를 7회 추가적으로 반복하는 단계;를 포함하는 발효홍삼의 제조방법을 제공한다.In order to achieve the above object, the present invention comprises the steps of (a) inoculating and fermenting strains of the genus Aspergillus (Spergillus) and / or Bacillus (Bacillus) to steamed ginseng once; (b) steaming and drying the fermented ginseng; And (c) repeating the step (b) seven times additionally.
본 발명은 또한, 상기 방법에 의해 제조된 발효홍삼 및 상기 발효홍삼을 포함하는 식품 조성물을 제공한다.The present invention also provides a fermented red ginseng prepared by the method and a food composition comprising the fermented red ginseng.
본 발명에 따른 발효홍삼의 제조방법을 이용하는 경우, 생리활성을 가지는 진세노사이드 Rg3 성분을 증가시키며 필요한 약리활성에 맞추어 간단하고 빠르게 발효홍삼을 제조할 수 있으므로, 질병치료제, 예방제 및 건강기능식품의 개발에 널리 활용될 수 있을 것이다. 또한, 본 발명에 따른 제조방법은 특별한 시설이나 장비를 요하지 않아 간단하고 비용면에서도 효율적이며, 선발된 균주만을 순수 배양하여 사용하기 때문에 다른 미생물과의 교차 오염의 문제점을 방지하는 효과가 있다.When using the method of manufacturing fermented red ginseng according to the present invention, it is possible to manufacture fermented red ginseng simply and quickly in accordance with the necessary pharmacological activity by increasing the ginsenoside Rg3 component having a physiological activity, the disease treatment, prevention and health functional foods of It can be widely used for development. In addition, the manufacturing method according to the present invention is simple and cost-effective because it does not require a special facility or equipment, and since only the selected strain is used by culturing purely, there is an effect of preventing the problem of cross contamination with other microorganisms.
도 1은 본 발명에 따른 발효홍삼 제조공정을 나타낸 모식도이다.
도 2는 Aspergillus oryzae, Bacillus subtilis 또는 혼합균주를 이용하여 제조된 발효홍삼의 진세노사이드 Rg3, Rg1, Rb1 함량을 나타낸 그래프이다.1 is a schematic diagram showing a fermented red ginseng manufacturing process according to the present invention.
2 Aspergillus oryzae , Bacillus It is a graph showing the ginsenoside Rg3, Rg1, Rb1 content of fermented red ginseng prepared using subtilis or mixed strain.
다른 식으로 정의되지 않는 한, 본 명세서에서 사용된 모든 기술적 및 과학적 용어들은 본 발명이 속하는 기술분야에서 숙련된 전문가에 의해서 통상적으로 이해되는 것과 동일한 의미를 갖는다. 일반적으로 본 명세서에서 사용된 명명법은 본 기술분야에서 잘 알려져 있고 통상적으로 사용되는 것이다.Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In general, the nomenclature used herein is well known and commonly used in the art.
본 발명자들은 가공된 인삼에만 존재하는 인삼사포닌 성분의 함량이 증가된 홍삼을 제조하는 방법을 개발하고자 노력한 결과, 인삼 또는 홍삼에 아스퍼질러스속 균을 접종하고 증숙공정과 건조공정을 총 9번 수행하여 인삼 사포닌 성분의 현저한 파괴없이 면역 및 생리활성에 효과가 있는 진세노사이드 Rg3 성분의 함량이 현저히 증가된 발효홍삼을 제조하였다.The present inventors have tried to develop a method for producing red ginseng with increased content of ginseng saponin components present only in processed ginseng, inoculated Aspergillus bacteria to ginseng or red ginseng, performing a steaming process and a drying process a total of nine times Fermented red ginseng was prepared with a significant increase in the content of ginsenoside Rg3, which is effective in immune and physiological activities without significant destruction of ginseng saponin.
따라서, 본 발명은 일 관점에서, (a) 1회 증숙한 인삼에 아스퍼질러스(Aspergillus) 속 균주 및/또는 바실러스(Bacillus) 속 균주를 접종하여 발효시키는 단계; (b) 상기 발효된 인삼을 증숙하고 건조하는 단계; 및 (c) 상기 (b) 단계를 7회 추가적으로 반복하는 단계;를 포함하는 발효홍삼의 제조방법에 관한 것이다.Accordingly, the present invention in one aspect, (a) the step of inoculating and fermentation strains of Aspergillus (Aspergillus) and / or Bacillus (Bacillus) strain in steamed ginseng once; (b) steaming and drying the fermented ginseng; And (c) repeating the step (b) seven times additionally.
본 발명에 있어서, 상기 인삼은 수삼을 세척한 후 증숙하여 제조할 수 있다.In the present invention, the ginseng can be prepared by steaming after washing the ginseng.
‘인삼’은 식물 분류학상 오가과 인삼속에 속하는 다년생 숙근초로서 지구상에 약 11종이 알려져 있으며, 대표적인 종의 예로는, 아시아 극동 지역(북위 33 ~ 48: 한국, 북만주, 러시아 일부)에 자생하며 약효가 매우 우수한 고려인삼(Panax ginseng C.A.Meyer); 미국, 캐나다에서 자생 및 재배하고 있는 미국삼(Panax quinquefolium L.); 중국 운남성 동남부로부터 광서성 서남부 지역에서 야생 또는 재배하고 있는 전칠삼(Panax notoginseng F.H.Chen); 및, 일본, 중국 서남부, 네팔에 이르기까지 분포되어 있는 죽절삼(Panax japonicus C.A.Meyer) 등이 있다. 현재 인삼의 사용은, 재배하여 채취한 상태 그대로의 수삼을 상온에서 건조시킨 백삼, 수삼을 가열 처리하여 제조되는 홍삼, 선삼 또는 흑삼 등의 형태로 사용되고 있다.'Ginseng' is a perennial ripening root belonging to the genus Oga ginseng according to the plant taxonomy, and about 11 species are known on the earth. For example, the ginseng is native to the Far East of Asia (North 33 ~ 48: Korea, North Manchuria, and Russia). Very good Panax ginseng CAMeyer; American ginseng (Panax quinquefolium L.) native and cultivated in the United States and Canada; Panax notoginseng F.H.Chen, wild or cultivated in southwestern Guangxi province from southeastern Yunnan Province, China; And Panax japonicus C.A.Meyer, which is distributed in Japan, southwest China, and Nepal. Currently, the use of ginseng is used in the form of red ginseng, ginseng, or black ginseng, which are produced by heating a white ginseng, dried ginseng as it is grown and harvested at room temperature.
본 발명에 있어서, 발효홍삼 제조에 사용되는 인삼은 공지된 다양한 삼을 사용할 수 있으며, 고려삼, 회기삼, 전칠삼, 죽절삼, 삼엽삼, 히말라야삼 및 베트남삼일 수 있으나, 이에 한정되는 것은 아니다. 본 발명의 일 실시예에서, 고려인삼을 사용하였다.In the present invention, the ginseng used in the fermented red ginseng may be used a variety of known ginseng, and may be Korean ginseng, hoegisam, jeonchisam, bamboo shoots, three leaf ginseng, Himalayan ginseng and Vietnamese ginseng, but is not limited thereto. In one embodiment of the present invention, Korean ginseng was used.
홍삼은 수삼으로부터 특수한 증숙, 건조 및 가공 공정을 통해 제조된 생약의 일종이다. 열처리에 따른 성분 변화로 인해 홍삼에는 진세노사이드(Rb1, Rb2, Rc, Rd, Rg1, Re 등) 및 항산화 활성 물질이 수삼이나 백삼에 비해 다량 함유되어 있고, 특유의 진세노사이드가 생성되기도 한다. 상기 여러 종류의 진세노사이드는 자양강장, 중추신경계 증상개선효과, 학습기능 증진, 기억력 향상, 생체 저항력 증진, 생체의 항상성 유지, 혈당 강하 기능, 해독 촉진 작용, 간 보호 및 재생, 심근세포보호 및 심기능 강화, 혈중콜레스테롤 함량저하, 혈압조절, 항암효과 등의 다양한 약리 효능이 있는 것으로 알려져 있다.Red ginseng is a kind of herbal medicine made from ginseng through special steaming, drying and processing processes. Due to the heat treatment, red ginseng contains ginsenosides (Rb1, Rb2, Rc, Rd, Rg1, Re, etc.) and antioxidant active substances in large amounts compared to ginseng or white ginseng, and also produces unique ginsenosides. . The various types of ginsenosides include nourishing tonic, central nervous system symptom-improving effect, learning function enhancement, memory improvement, bio-resistance enhancement, homeostasis maintenance, hypoglycemic function, detoxification action, liver protection and regeneration, cardiomyocyte protection and It is known to have various pharmacological effects such as strengthening of heart function, lowering blood cholesterol content, controlling blood pressure, and anticancer effect.
본 명세서에서, 용어 ‘증숙(蒸熟)’은 ‘증자’와 동일한 의미로 사용되며, 수삼 또는 인삼으로부터 홍삼을 제조하기 위해 쪄서(또는 삶아서) 익히는 공정을 의미한다.In the present specification, the term 'jet mature' is used in the same sense as 'capsicum' and refers to a process of steaming (or boiling) ripening to produce red ginseng from fresh ginseng or ginseng.
본 발명에 있어서, 상기 (a) 단계의 증숙은 70 내지 110℃에서 3 내지 6시간 동안 증숙하는 것을 특징으로 할 수 있다.In the present invention, the steaming of step (a) may be characterized in that steaming for 3 to 6 hours at 70 to 110 ℃.
본 발명에 있어서, 상기 아스퍼질러스(Aspergillus) 속 균주는 유익균인 아스퍼질러스 오리재(Aspergillus oryzae), 아스퍼질러스 니제르(Aspergillus niger), 아스퍼질러스 우사미(Aspergillus usamii), 아스퍼질러스 시로우사미(Aspergillus shirousamii), 아스퍼질러스 아와모리(Aspergillus awamori) 또는 아스퍼질러스 카와치(Aspergillus kawachii)인 것을 특징으로 할 수 있으며, 바람직하게는 아스퍼질러스 오리재(Aspergillus oryzae)인 것을 특징으로 할 수 있다.In the present invention, the strain of the genus Aspergillus (Aspergillus) is a beneficial bacterium Aspergillus duck ( Aspergillus oryzae ), Aspergillus niger ( Aspergillus niger) niger), Usami Aspergillus (Aspergillus usamii), Aspergillus Shiro Usami (Aspergillus shirousamii ), Aspergillus awamori or Aspergillus kawachii , and may be characterized as being preferably Aspergillus oryzae .
본 발명에 있어서, 상기 바실러스(Bacillus) 속 균주는 유익균인 바실러스 서브틸리스(Bacillus subtilis) 또는 바실러스 코아귤런스(Bacillus coagulans)인 것을 특징으로 할 수 있으며, 바람직하게는 바실러스 서브틸리스(Bacillus subtilis)인 것을 특징으로 할 수 있다.In the present invention, the Bacillus genus strain may be characterized as Bacillus subtilis ( Bacillus subtilis ) or Bacillus coagulans ( Bacillus subtilis ) which is a beneficial bacterium , preferably Bacillus subtilis It can be characterized by the).
접종균 Aspergillus oryzae는 메주 제조 등에 사용하는 황국균으로, 1회 증숙한 인삼에 상기 접종균을 접종하고, 접종한 인삼은 발효실에서 24시간 ~ 48시간 발효할 수 있다.Inoculation Aspergillus oryzae is a sulfur bacterium used for preparing meju, and the inoculation bacterium is inoculated into steamed ginseng once, and the inoculated ginseng can be fermented in a fermentation chamber for 24 to 48 hours.
본 발명에 있어서, 상기 (a) 단계의 발효는 30 내지 40℃에서 24 내지 48시간 동안 발효시키는 것을 특징으로 할 수 있다.In the present invention, the fermentation of step (a) may be characterized in that the fermentation for 24 to 48 hours at 30 to 40 ℃.
본 발명에 있어서, 상기 (b) 단계의 증숙은 70 내지 110℃에서 3 내지 6시간 동안 증숙하고, 건조는 30 내지 50℃에서 3 내지 12시간 동안 건조하는 것을 특징으로 할 수 있다. 상기 건조는 열풍건조일 수 있다.In the present invention, the steaming step (b) is steamed for 3 to 6 hours at 70 to 110 ℃, drying may be characterized in that the drying for 3 to 12 hours at 30 to 50 ℃. The drying may be hot air drying.
본 발명의 일 실시예에서, 균주 접종 전 1회 증숙, Aspergillus oryzae , Bacillus subtilis 또는 이들의 혼합균주 접종 및 발효 후 8회 증숙 단계를 포함하여 총 9회 증숙 및 건조 단계를 거쳐 발효홍삼을 제조하였다. 증숙 및 건조 단계가 9회보다 적거나, 10회 이상인 경우 제조된 발효홍삼의 Rg3 함량이 낮은 문제가 있으므로, 총 9회 증숙 및 건조 단계를 포함하는 것이 Rg3 함량을 높이면서 가장 효율적인 제조방법임을 확인하였다.In one embodiment of the present invention, steaming once before inoculating the strain, Aspergillus oryzae , Bacillus Fermented red ginseng was prepared through a total of nine steaming and drying steps including subtilis or mixed strains thereof and eight steaming steps after fermentation. If the steaming and drying step is less than 9 times, or more than 10 times, there is a problem that the Rg3 content of the fermented red ginseng produced is low, so including a total of 9 steaming and drying steps is the most efficient manufacturing method while increasing the Rg3 content It was.
본 발명에 있어서, 상기 제조된 발효홍삼의 진세노사이드(ginsenoside) Rg3 함량이 2.30 내지 5.02mg/g인 것을 특징으로 할 수 있다.In the present invention, the ginsenoside (ginsenoside) Rg3 content of the prepared fermented red ginseng may be characterized in that 2.30 to 5.02mg / g.
본 발명에 있어서, 상기 ‘발효홍삼’은 인삼에 미생물을 접종한 후 발효시켜 수득한 발효된 인삼을 의미한다.In the present invention, 'fermented red ginseng' refers to fermented ginseng obtained by fermentation after inoculating microorganisms into ginseng.
본 발명은 다른 관점에서, 상기 방법을 이용하여 제조되고, 진세노사이드(ginsenoside) Rg3 함량이 2.30 내지 5.02mg/g인 발효홍삼에 관한 것이다.In another aspect, the present invention relates to a fermented red ginseng prepared using the above method and having a ginsenoside Rg3 content of 2.30 to 5.02 mg / g.
홍삼 특유의 유효성분인 진세노사이드를 포함하는 다양한 제품들이, 예컨대, 농축, 분말, 캡슐, 액상 제제, 음료 등의 다양한 형태로 가공되어 판매되고 있다. 이 중 액상 제제, 음료 등은 복용이 간편하고 흡수가 빠르다는 장점이 있어 소비자에게 높은 선호도를 보인다.Various products including ginsenoside, an active ingredient unique to red ginseng, are processed and sold in various forms such as concentrated, powder, capsules, liquid formulations, and beverages. Among them, liquid preparations, beverages, etc. are easy to take and quick absorption shows high preference for consumers.
본 발명에 있어서, 상기 발효홍삼은 농축, 분말, 캡슐, 액상 제제, 음료 등의 다양한 형태로 가공될 수 있으며, 바람직하게는 액상 제제로 가공될 수 있다. 상기 액상 제제는 홍삼의 추출액, 침출액 등으로 홍삼으로부터 유래 되는 모든 액체를 포함한다.In the present invention, the fermented red ginseng may be processed into various forms such as concentrate, powder, capsule, liquid formulation, beverage, and preferably, liquid formulation. The liquid formulation includes all liquids derived from red ginseng as extracts, leaching liquids, and the like of red ginseng.
본 발명에 따른 제조방법을 이용하여 제조된 발효홍삼은 우수한 사포닌 함량을 가지므로, 건강식품뿐만 아니라 의약품, 화장품 및 사료용 조성물의 원료로도 이용될 수 있다.Fermented red ginseng prepared using the manufacturing method according to the present invention has an excellent saponin content, it can be used as a raw material of the composition for pharmaceuticals, cosmetics and feed as well as health food.
본 발명은 또 다른 관점에서, 상기 발효홍삼을 포함하는 식품 조성물에 관한 것이다.In another aspect, the present invention relates to a food composition comprising the fermented red ginseng.
본 발명에 있어서, 상기 식품은 예를 들면 각종 건강식품, 갱년기 및 노인성 식품, 미용식품 등의 각종 식품류, 음료, 껌, 차, 비타민 복합제 등을 포함한다. 상기 조성물은 독성 및 부작용이 거의 없으므로 예방 목적으로 장기간 복용시에도 안심하고 사용할 수 있는 약제이다.In the present invention, the food includes various foods such as various health foods, menopausal and senile foods, beauty foods, beverages, gums, teas, vitamin complexes and the like. Since the composition has little toxicity and side effects, it is a drug that can be used safely even for long-term administration for the purpose of prevention.
상기 식품 조성물에 첨가될 수 있는 발효홍삼의 양은 일반적으로 전체 식품 중량의 0.01 내지 15 중량%로 가할 수 있으며, 식품 건강 음료 조성물은 100ml 기준으로 0.02 내지 10g, 바람직하게는 0.3 내지 1g이다.The amount of fermented red ginseng that can be added to the food composition may generally be added in an amount of 0.01 to 15% by weight of the total food weight, and the food health beverage composition is 0.02 to 10 g, preferably 0.3 to 1 g, based on 100 ml.
본 발명에 따른 발효홍삼을 함유하는 건강 음료의 성분은 특별한 제한이 없으며, 통상의 음료와 같이, 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로 포함할 수 있다. 상기 천연 탄수화물의 예로는 포도당, 과당, 말토오스, 수크로오스, 덱스트린, 시클로 덱스트린 등의 통상의 당 및 자일리톨, 솔비톨, 에리스리톨 등의 당알콜을 포함할 수 있다. 또한, 타우마틴 및 스테비아 추출물를 포함하는 천연 향미제, 및 사카린 아스파탐 등의 인공 감미료도 유리하게 사용될 수 있다.The component of the health beverage containing fermented red ginseng according to the present invention is not particularly limited, and may include various flavors or natural carbohydrates as additional components, as in general beverages. Examples of the natural carbohydrate may include conventional sugars such as glucose, fructose, maltose, sucrose, dextrin, cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. In addition, natural sweeteners, including taumartin and stevia extract, and artificial sweeteners such as saccharin aspartame may also be advantageously used.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로서, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지 않는 것은 당업계에서 통상의 지식을 가진 자에 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention, it will be apparent to those skilled in the art that the scope of the present invention is not to be construed as limited by these examples.
실시예Example 1: One: 증숙Steaming 횟수에 따른 홍삼의 Of red ginseng according to the number of times Rg3Rg3 함량 비교 Content comparison
4~5년근 수삼을 구입(경북영주, 희망인삼사(난발삼))한 후 세척하고 증숙기에서 80℃, 3시간 증숙하고, 40℃에서 8시간 동안 건조시키는 공정으로 인삼을 제조하여 시료를 채취하였다.Purchasing 4 ~ 5 years old ginseng (Gyeongbuk Yeongju, Hope ginseng yarn (Nanbal ginseng)), washing, steaming at 80 ℃ for 3 hours in steamer, drying at 40 ℃ for 8 hours to collect sample It was.
하기 표 1에 나타낸 바와 같이, 증숙공정의 횟수가 3회에서 9회로 증가할 경우, Rg3 함량은 증가하는 양상을 나타내었다.As shown in Table 1 below, when the number of steaming processes increased from 3 to 9 times, the Rg3 content was increased.
9회 증숙하여 홍삼을 제조한 결과, 3회 증숙보다는 Rg3의 함량이 현저하게 증가됨을 확인하였다. 또한, 10회 증숙하는 경우 Rg3의 함량이 9회 증숙하는 경우보다 오히려 감소되므로, 10회 이상 증숙하는 경우 유효성분의 소실이 예상됨을 확인하였다.As a result of preparing red ginseng by steaming 9 times, it was confirmed that the content of Rg3 was significantly increased rather than steaming 3 times. In addition, when steaming 10 times, the content of Rg3 decreases rather than steaming 9 times, and when steaming 10 times or more, it was confirmed that the loss of the active ingredient is expected.
실시예Example 2: 미생물을 이용한 발효 홍삼의 진세노사이드 2: Ginsenosides of Fermented Red Ginseng Using Microorganisms Rg3Rg3 증진 분석 Enhancement analysis
3회 증숙한 홍삼, 9회 증숙한 홍삼, 9회 증숙 및 Aspergillus oryzae 균주(㈜충무발효(울산, 울주군), “황국”(메주제조시 사용하는 메주균))를 접종한 홍삼, 9회 증숙 및 Bacillus subtillus 균주(발효미생물산업진흥원, SCK115022)를 접종한 홍삼 또는 9회 증숙 및 Aspergillus oryzae 균주와 Bacillus subtillus 균주의 혼합 균주를 접종한 홍삼을 준비하였다. Aspergillus oryzae 및 Bacillus subtillus 의 혼합 균주에서 혼합비는 임의적일 수 있으며, 각 균주의 접종 함량은 일반적인 접종 기준에 의하여 수행하였다. 바람직하게, 균주의 접종 후 발효 일수는 최소 1일 이상에서 2일 이내로 설정할 수 있으며, 조건에 따라서 변경될 수도 있다. 균주의 종류가 2종 이상일 경우, 각 균주마다 차례로 배양되거나 함께 배양될 수 있다.3 steamed red ginseng, 9 steamed red ginseng, 9 steamed and Aspergillus Red ginseng inoculated with oryzae strains (Chungmu fermentation (Ulsan, Ulju-gun), “Hwangguk” (meju) used in manufacturing meju), 9 steams and Bacillus subtillus strains (fermented microbial Industry Development Institute, SCK115022) a ginseng or 9th steaming and inoculated Aspergillus Red ginseng was inoculated with a mixed strain of oryzae and Bacillus subtillus strains. Aspergillus oryzae and Bacillus In the mixed strains of subtillus, the mixing ratio may be arbitrary, and the inoculation content of each strain was performed according to general inoculation criteria. Preferably, the number of days of fermentation after inoculation of the strain may be set within at least 1 day to within 2 days, and may be changed depending on conditions. When two or more kinds of strains are used, each strain may be cultured in turn or in combination.
홍삼에 각 균주를 접종하여 배양 및 발효시킨 후, 발효홍삼의 Rg3 함량을 비교하였다.After inoculating each strain into red ginseng, cultured and fermented, the Rg3 content of fermented red ginseng was compared.
그 결과, 하기 표 2에 나타낸 바와 같이, 실험군 1번(3회 증자)보다 실험군 2번(9회 증자, Aspergillus oryzae)에서 Rg3의 함량이 평균 4~5배 증가한 것을 확인하였다.As a result, as shown in Table 2, it was confirmed that the average content of Rg3 in the experimental group 2 (9 times, Aspergillus oryzae ) increased by an average of 4 to 5 times than the experimental group 1 (three times).
1번: 3회 증자, 무균1st increase of 3 times, sterile
2번: Aspergillus oryzae - 9회 증자, 단일균주Number 2: Aspergillus oryzae -9 increase, single strain
3번: Bacillus subtillus - 9회 증자, 단일균주Number 3: Bacillus subtillus -9 increase, single strain
4번: Aspergillus oryzae + Bacillus subtillus - 9회 증자, 혼합균주(홍삼 1.3kg 기준, 5배 희석한 B. subtillus 50g(균주 100ml+물 400ml) + A. oryzae 20g)Number 4: Aspergillus oryzae + Bacillus subtillus -9 times, mixed strain (based on 1.3kg of red ginseng, 50g B. subtillus diluted 100 times (100ml of strain + 400ml of water) + A. oryzae 20g)
5번: Aspergillus oryzae + Bacillus subtillus - 9회 증자, 혼합균주(홍삼 1.3kg 기준, 5배 희석한 B. subtillus 25g(균주 100ml+물 400ml) + A. oryzae 10g)Number 5: Aspergillus oryzae + Bacillus subtillus -9 times increase, mixed strain (based on 1.3kg of red ginseng, 5 times diluted B. subtillus 25g (100ml of strain + 400ml of water) + A. oryzae 10g)
가장 효과적으로 Rg3 함량을 증가시킬 수 있는 방법을 검토한 결과, Aspergillus oryzae 균주를 접종하여 총 9회 증숙·건조하여 발효시키는 공정이 바람직했다(도 2). Aspergillus finds the most effective way to increase Rg3 content Inoculating oryzae strain was preferred to steam and dry a total of nine times to ferment (Fig. 2).
이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적 기술은 단지 바람직한 실시 양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.As described above in detail specific parts of the present invention, it will be apparent to those skilled in the art that these specific descriptions are merely preferred embodiments, and thus the scope of the present invention is not limited thereto. will be. Thus, the substantial scope of the present invention will be defined by the appended claims and their equivalents.
Claims (8)
(b) 상기 발효된 인삼을 70 내지 110℃에서 3 내지 6시간 동안 증숙하고 30 내지 50℃에서 3 내지 12시간 동안 건조하는 단계; 및
(c) 상기 (b) 단계를 7회 추가적으로 반복하는 단계;를 포함하는 발효홍삼의 제조방법.
(a) 30 to 40 ° C by inoculating Aspergillus strain, Bacillus subtilis or Bacillus coagulans in ginseng steamed at 70 to 110 ° C for 3 to 6 hours Fermentation for 24 to 48 hours;
(b) steaming the fermented ginseng for 3 to 6 hours at 70 to 110 ℃ and drying for 3 to 12 hours at 30 to 50 ℃; And
(c) repeating the step (b) additionally seven times.
The method of claim 1, wherein the Aspergillus genus strains are Aspergillus oryzae , Aspergillus niger , Aspergillus usamii , Aspergillus sirousami Aspergillus shirousamii ), Aspergillus awamori ( Aspergillus awamori ) or Aspergillus kawachii ( Aspergillus kawachii ) The manufacturing method of fermented red ginseng, characterized in that.
The method for preparing fermented red ginseng according to claim 1, wherein the prepared ginsenoside Rg3 content is 2.30 to 5.02 mg / g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190067948A KR102052530B1 (en) | 2019-06-10 | 2019-06-10 | Manufacturing Method of Fermented Red Ginseng Using Steamed Ginseng and Microorganism |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190067948A KR102052530B1 (en) | 2019-06-10 | 2019-06-10 | Manufacturing Method of Fermented Red Ginseng Using Steamed Ginseng and Microorganism |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102052530B1 true KR102052530B1 (en) | 2019-12-06 |
Family
ID=68837255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190067948A KR102052530B1 (en) | 2019-06-10 | 2019-06-10 | Manufacturing Method of Fermented Red Ginseng Using Steamed Ginseng and Microorganism |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102052530B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102445444B1 (en) * | 2021-12-09 | 2022-09-22 | 주식회사 나투어바이오제약 | A method for improving preparation of fermented black ginseng containing high content of functional ingredients based on safety |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110105287A (en) * | 2010-03-18 | 2011-09-26 | 동국대학교 산학협력단 | Manufacturing method of fermentative red ginseng |
KR20110105286A (en) * | 2010-03-18 | 2011-09-26 | 동국대학교 산학협력단 | Manufacturing method of fermentative red ginseng |
KR20140063948A (en) * | 2012-11-19 | 2014-05-28 | 재단법인 금산국제인삼약초연구소 | Manufacturing method of fermented red ginseng extract with enhanced ginsenosides rg3 and antioxidant activity |
KR101423100B1 (en) * | 2014-01-17 | 2014-07-25 | 백제홍삼 주식회사 | Fabrication method of enhancing ginsenoside Rg3 and Rb1 of red ginseng |
KR101670810B1 (en) * | 2015-11-27 | 2016-10-31 | 재단법인 금산국제인삼약초연구소 | A method for manufacturing a fermented black ginseng containing the increased amount of minor ginsenosides, and the fermented black ginseng thereof |
KR101683478B1 (en) * | 2014-12-22 | 2016-12-08 | 재단법인 전주농생명소재연구원 | Method for producing fermented red ginseng with enhanced ginsenoside Rg3 content |
-
2019
- 2019-06-10 KR KR1020190067948A patent/KR102052530B1/en active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110105287A (en) * | 2010-03-18 | 2011-09-26 | 동국대학교 산학협력단 | Manufacturing method of fermentative red ginseng |
KR20110105286A (en) * | 2010-03-18 | 2011-09-26 | 동국대학교 산학협력단 | Manufacturing method of fermentative red ginseng |
KR20140063948A (en) * | 2012-11-19 | 2014-05-28 | 재단법인 금산국제인삼약초연구소 | Manufacturing method of fermented red ginseng extract with enhanced ginsenosides rg3 and antioxidant activity |
KR101423100B1 (en) * | 2014-01-17 | 2014-07-25 | 백제홍삼 주식회사 | Fabrication method of enhancing ginsenoside Rg3 and Rb1 of red ginseng |
KR101683478B1 (en) * | 2014-12-22 | 2016-12-08 | 재단법인 전주농생명소재연구원 | Method for producing fermented red ginseng with enhanced ginsenoside Rg3 content |
KR101670810B1 (en) * | 2015-11-27 | 2016-10-31 | 재단법인 금산국제인삼약초연구소 | A method for manufacturing a fermented black ginseng containing the increased amount of minor ginsenosides, and the fermented black ginseng thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102445444B1 (en) * | 2021-12-09 | 2022-09-22 | 주식회사 나투어바이오제약 | A method for improving preparation of fermented black ginseng containing high content of functional ingredients based on safety |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101362351B1 (en) | Ginseng process method for increasing ginsenoside quantity and processed goods thereof | |
KR20160013731A (en) | Preparation method of ginseng fermentation product enhanced ginsenoside Rh2 and Rg3 content | |
KR101482873B1 (en) | Fermentation metabolite of Dendropanax morbiferus produced by liquid-state fermentation and manufacturaring process for the same | |
CN101780128B (en) | Preparation method of brown ginseng | |
KR101274755B1 (en) | Red ginseng with enhanced specific gensenoside content and producing method thereof | |
KR101372400B1 (en) | A manufacturing method of red ginseng staf4h with enhanced trace ginsenoside | |
KR102052530B1 (en) | Manufacturing Method of Fermented Red Ginseng Using Steamed Ginseng and Microorganism | |
KR101363074B1 (en) | Functional red ginseng or red ginseng powder with enhanced 21 type saponin and ginsenoside content and producing method thereof | |
CN113893310A (en) | Mountain plant fermentation composition and preparation method and application thereof | |
KR20210029444A (en) | Beverage composition containing high fermented mountain-cultivated ginseng and preparation method thereof | |
KR20170061961A (en) | Manufacturing method of liquors | |
Ma et al. | Nutritional value and processing technology of mulberry fruit products | |
KR20200078171A (en) | The manufacturing method of fermented red ginseng extracts enhanced with ginsenoside compound K, Rd and Rd3 using β-glucosidase and lactic acid bacteria | |
CN107041445A (en) | A kind of bamboo juice leaf of bamboo health protection tea for preventing and treating hypertension, hyperglycemia | |
CN108578589B (en) | Composite effervescent tablet for relieving alcoholism and preparation method thereof | |
CN112457359A (en) | Method for preparing converted ginsenoside from ginseng fruit and preparation thereof | |
KR20210043273A (en) | Liquid tea containing fermented mountain-cultivated ginseng and preparation method thereof | |
CN107509838A (en) | A kind of preparation method of fermented black rice tea | |
KR20210084788A (en) | Method of growing shiitake mushrooms with improved beta glucan content and yield | |
KR20190099943A (en) | A method for manufacturing using fermented orostachys malacophyllus and the health drink including fermented black ginseng and fermented orostachys malacophyllus | |
KR102627124B1 (en) | Manufacturing method of Jelly Stick using Wood Cultivated Ginseng | |
KR102259131B1 (en) | The manufacturing method of fermented red ginseng extracts enhanced with ginsenoside compound K, Rd and Rd3 using β-glucosidase and lactic acid bacteria | |
KR102386062B1 (en) | Ginseng saponin complex GINOS with enhanced active saponins and uses thereof | |
KR101609785B1 (en) | Manufacturing method of honeyed ginseng having ginseng hydrolysis concentrate | |
KR102568831B1 (en) | Manufacturing Method of Wild Ginseng Syrup |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |